OBJECTIVES: Usher's syndrome is an autosomal recessive disorder characterized by sensorineural hearing loss and progressive visual loss secondary to retinitis pigmentosa. Usher's syndrome is both clinically and genetically heterogeneous. Three clinical types are known today. METHODS: We conducted a study on 74 patients with Usher's syndrome, performing complete audiological and neurotological examinations. RESULTS: Twenty-six patients had total profound hearing loss and retinitis pigmentosa (Usher's syndrome type I), and 48 patients had moderate to severe sensorineural hearing loss and retinitis pigmentosa (Usher's syndrome type II). We identified 9 of the 26 Usher's syndrome patients with profound hearing loss who showed a normal response to bithermal vestibular testing. CONCLUSIONS: The combination of profound hearing loss and normal response to bithermal vestibular testing has not been previously described in Usher's syndrome. Therefore we describe a new subtype of Usher's syndrome type I and suggest a modified clinical classification for Usher's syndrome.
OBJECTIVES:Usher's syndrome is an autosomal recessive disorder characterized by sensorineural hearing loss and progressive visual loss secondary to retinitis pigmentosa. Usher's syndrome is both clinically and genetically heterogeneous. Three clinical types are known today. METHODS: We conducted a study on 74 patients with Usher's syndrome, performing complete audiological and neurotological examinations. RESULTS: Twenty-six patients had total profound hearing loss and retinitis pigmentosa (Usher's syndrome type I), and 48 patients had moderate to severe sensorineural hearing loss and retinitis pigmentosa (Usher's syndrome type II). We identified 9 of the 26 Usher's syndromepatients with profound hearing loss who showed a normal response to bithermal vestibular testing. CONCLUSIONS: The combination of profound hearing loss and normal response to bithermal vestibular testing has not been previously described in Usher's syndrome. Therefore we describe a new subtype of Usher's syndrome type I and suggest a modified clinical classification for Usher's syndrome.
Authors: Chris R S Kaneko; Sam Rosenfeld; Ethan Fontaine; Alex Markov; James O Phillips; John Yarno Journal: J Neurosci Methods Date: 2010-09-15 Impact factor: 2.390
Authors: Erwin van Wijk; Ronald J E Pennings; Heleen te Brinke; Annemarie Claassen; Helger G Yntema; Lies H Hoefsloot; Frans P M Cremers; Cor W R J Cremers; Hannie Kremer Journal: Am J Hum Genet Date: 2004-03-10 Impact factor: 11.025
Authors: Magnus Teschner; Juergen Neuburger; Roland Gockeln; Thomas Lenarz; Anke Lesinski-Schiedat Journal: Eur Arch Otorhinolaryngol Date: 2007-12-06 Impact factor: 2.503
Authors: Suhasini R Gopal; Daniel H-C Chen; Shih-Wei Chou; Jingjing Zang; Stephan C F Neuhauss; Ruben Stepanyan; Brian M McDermott; Kumar N Alagramam Journal: J Neurosci Date: 2015-07-15 Impact factor: 6.167
Authors: Qi Zhou; Chaeli Lenger; Richard Smith; William J Kimberling; Ming Ye; Ordan Lehmann; Ian MacDonald Journal: Mol Vis Date: 2012-05-31 Impact factor: 2.367
Authors: Scott F Geller; Karen I Guerin; Meike Visel; Aaron Pham; Edwin S Lee; Amiel A Dror; Karen B Avraham; Toshinori Hayashi; Catherine A Ray; Thomas A Reh; Olivia Bermingham-McDonogh; William J Triffo; Shaowen Bao; Juha Isosomppi; Hanna Västinsalo; Eeva-Marja Sankila; John G Flannery Journal: PLoS Genet Date: 2009-08-14 Impact factor: 5.917